SEP 9, 2026 · PHASE 1 TRIAL
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD)
ClinicalTrials.gov
This is a Phase 1 clinical trial registry record with no results posted; it describes planned safety and tolerability assessment in a small early-stage cohort.
Reported
Planned enrollment6
Study phasePhase 1
Primary outcome measure 1Percentage of Participants with Adverse Eve…